Skip to main content

Health economic modeling for medical technologies in Europe

Early and comprehensive economic models to determine economic value proposition and inform healthcare decision-makers

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Medtech-related HTAs in Wales published in March 2023

17 May 2023

Health Technology Wales (HTW) is a national body working to improve the quality of care in Wales. It is funded by Welsh Government and hosted within NHS Wales but independent of both. HTW covers medical devices, diagnostics, procedures, psychological therapies, models of care, and social care support, excluding pharmaceuticals.

Anyone can suggest a topic, and HTW also performs active horizon scanning. HTW uses a staged process of assessment by developing three types of documents. The topic exploration report (TER) aimed to assess whether there is enough available evidence to proceed with a full appraisal and whether the topic meets the appraisal selection criteria. Based on the TER conclusions, HTW's Assessment Group decides whether to progress this topic further. If yes, the following two documents are developed: Evidence Appraisal Report (EAR) and Guidance (GUI).

Recommendations are not mandatory; the status of HTW guidance is "adopt or justify," meaning that the local health board and other relevant bodies are expected to report on how they have considered the appraisal and guidance. If they have chosen not to adopt HTW guidance, they are asked to outline their rationale and justify their decision.

In March 2023, one full appraisal was completed on photobiomodulation for the prevention and treatment of oral mucositis associated with cancer treatment. HTW concluded that the evidence is insufficient to support routine adoption.

In March 2023, HTW published TER on digital tools for the monitoring and management of wounds focused on tools that use the “store-and-forward” technique, where patient information is recorded and sent to a healthcare professional for review. HTW decided to develop a full appraisal on this topic.

Furthermore, six Medtech-related TERs were published in March 2023, for which HTW will not with full appraisals. Some of those topics are provided below:

  • AI-assisted ultrasound for deep vein thrombosis;
  • Single pulse transcranial magnetic stimulation for the acute treatment or prevention of migraines;
  • Digital companion robots to deliver remote care.

See the full details here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Contact us to get a free, three-month, no-obligation trial.